CASP1 and Zika virus infectious disease: Nevertheless, in our preliminary assessment for the therapeutic effect of caspase-1 inhibitor VX765, its inhibition of cell death and inflammation caused by ZIKV infection was suboptimal, suggesting that ZIKV may also induce other forms of inflammation-associated cell death.